ISDS Case Map
Canada
Canada's first week as a full-fledged member of the Trans-Pacific Partnership has been … well … a little dull, writes Stuart Trew
Should the government of Canada sign agreements if they subject our workers to unfair competition from lower-paid employees from investor nations, hinder our ability to protect the environment or give foreign companies and governments excessive control over local policies and valuable resources?, asks David Suzuki
The government aims to secure a stable supply of resources such as natural gas and oil by entering negotiations Monday with Canada to conclude an economic partnership agreement. Whether Japan can overcome differences of opinion with Canada over liberalization of agricultural products will be a test for the government in promoting other trade negotiations, including those for the Trans-Pacific Partnership multilateral trade talks.
The European Union wants Canada to agree to compensate European companies for any losses that stem from changes to health, environment or safety rules in Canada, according to documents obtained by The Canadian Press.
Japan and Canada opened their first round of talks Monday on a bilateral free trade agreement that would eliminate tariff barriers on both sides.
The Ministry of Petroleum and Natural Resources (MoPNR) has written a letter to Prime Minister Raja Pervez Ashraf to persuade the Balochistan government to settle the Reko Diq issue out of court, fearing a penalty of Rs39 billion by the International Centre for Settlement Investment Disputes (ICSID).
Trade negotiations next week between Canada and the European Union will reach a point familiar to anyone who's purchased a new car.
A US-incorporated energy firm, Lone Pine Resources Inc., is taking on Quebec's stand against fracking, saying it violates the North American free-trade agreement and demanding more than $250-million in compensation.
As free trade talks with the European Union reach the endgame, Ottawa is signalling it is prepared to give the Europeans at least part of what they asked for on drug patents — a move that could cost Canadians up to $900 million a year.
